Lys Therapeutics

Lyon, France

Lys Therapeutics develops drugs to treat patients suffering from neurovascular or neurodegenerative disorders.

Sep 2025

Grant

Biotechnology Health Care Life Science Medical

Top Investors

BpifranceMichael J. Fox FoundationNormandie IncubationHTHPulsalys

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lys Therapeutics

Who are Lys Therapeutics's investors?

Lys Therapeutics's investors include Bpifrance, Michael J. Fox Foundation, Normandie Incubation, HTH, Pulsalys.

Where is Lys Therapeutics headquartered?

Lys Therapeutics is headquartered in Lyon, France.

What does Lys Therapeutics do?

Lys Therapeutics develops drugs to treat patients suffering from neurovascular or neurodegenerative disorders.

What stage is Lys Therapeutics at?

Lys Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 22, 2025.

MLA

"Lys Therapeutics — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/lys-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2025). Lys Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/lys-therapeutics

Wikipedia (cite web)

{{cite web |title=Lys Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lys-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 22, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.